1160882

Teva Pharmaceuticals USA, Inc — FEI 3003092769

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 16, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)